Urovison en es it fr

Urovison Brand names, Urovison Analogs

Urovison Brand Names Mixture

  • No information avaliable

Urovison Chemical_Formula


Urovison RX_link

No information avaliable

Urovison fda sheet

Urovison msds (material safety sheet)

Urovison Synthesis Reference

No information avaliable

Urovison Molecular Weight

241.247 g/mol

Urovison Melting Point

250-255 oC (hydrochloride salt)

Urovison H2O Solubility

>20 mg/mL (dichloride salt)

Urovison State


Urovison LogP


Urovison Dosage Forms

No information avaliable

Urovison Indication

For the treatment of tetrahydrobiopterin (BH4) deficiency.

Urovison Pharmacology

Tetrahydrobiopterin (BH4) is used to convert several amino acids, including phenylalanine, to other essential molecules in the body including neurotransmitters. Tetrahydrobiopterin deficiency can be caused by mutations in GTP cyclohydrolase 1 (GCH1), 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), 6-pyruvoyltetrahydropterin synthase (PTS), and quinoid dihydropteridine reductase (QDPR) genes. These genes make the enzymes that are critical for producing and recycling tetrahydrobiopterin. If one of the enzymes fails to function correctly because of a gene mutation, little or no tetrahydrobiopterin is produced. As a result, phenylalanine from the diet builds up in the bloodstream and other tissues and can damage nerve cells in the brain. High levels of phenylalanine can result in signs and symptoms ranging from temporary low muscle tone to mental retardation, movement disorders, difficulty swallowing, seizures, behavioral problems, progressive problems with development, and an inability to control body temperature.

Urovison Absorption

No information avaliable

Urovison side effects and Toxicity

No information avaliable

Urovison Patient Information

No information avaliable

Urovison Organisms Affected

Humans and other mammals